Getinge Year End Report 2022:“External challenges remain but are expected to ease in 2023”
“The order intake and net sales declined organically by 6.7% and 5.3% during the quarter, mainly as a result of continuing external challenges,” says Mattias Perjos, President & CEO of Getinge. “Hospitals have not yet recovered to pre-pandemic levels for elective surgery, are generally experiencing lower productivity than before the pandemic, and have low treatment needs related to seasonal influenza”.Getinge reports challenging comparative figures in products for COVID-19 treatment and vaccine production and the challenges in the supply chain continue, which negatively impacted net sales